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The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy
Chung-Pu Wua,b,c, Suresh V. Ambudkard
aDepartment of Physiology and Pharmacology, College of Medicine, Chang Gung University, Tao-Yuan
bMolecular Medicine Research Center, College of Medicine, Chang Gung University, Tao-Yuan
cGraduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Tao-Yuan
dLaboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
This review highlights some of the recent ﬁndings related to the effect of ABC drug transporters such as ABCB1 and ABCG2 on
the oral bioavailability of vemurafenib, problems associated with treating melanoma brain metastases and the development of
acquired resistance to vemurafenib in cancers harboring the BRAF (V600E) mutation.
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Research and development in drug innovation: reﬂections from the 2013
bioeconomy conference in China, lessons learned and future perspectives
a b aChangxiao Liu , Panayiotis P. Constantinides , Yazhuo Li
aTianjin Institute of Pharmaceutical Research, Tianjin 300193, China
bBiopharmaceutical and Drug Delivery Consulting, LLC, Gurnee, IL 60031, USA
The enormous progress biotechnology, bioinformatics and nanotechnology made in recent
years provides opportunities and scientiﬁc framework for development of biomedicine and
constitutes a paradigm shift in pharmaceutical R&D and drug innovation. By analyzing the data
and related information at R&D level over the past decades, developmental tendency and
R&D patterns were summarized.
Acta Pharmaceutica Sinica B, 4 (2014) 120
Smart polymers for the controlled delivery of drugs – a concise overviewHoney Priya James, Rijo John, Anju Alex, Anoop K.R.
Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa
Vidyapeetham University, AIMS Healthcare Campus, Kochi, Kerala 682041, India
This review discusses various mechanisms by which polymer systems are assembled in situ to
form implanted devices for sustained release of therapeutic macromolecules, and highlights
various applications in the ﬁeld of advanced drug delivery.
Open access under CC BY-NC-ND license.
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RasGAP-derived peptide GAP159 enhances cisplatin-induced cytotoxicity and apoptosis
in HCT116 cells
Hao Zhanga, Shenghua Zhanga, Hongwei Hea, Caixia Zhanga, Yi Chena,
Dongke Yua, Jianhua Chenb, Rongguang Shaoa
aInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical
College, Beijing 100050, China
bWuhan KatyGen Pharmaceuticals, Inc., Wuhan 430074, China
GAP159, a synthetic RasGAP-derived peptide, targets and down-regulates G3BP, enhances cisplatin induced
cytotoxicity and apoptosis in HCT116 cells in vitro and mouse colon tumor CT26 animal models in vivo.
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Establishment of a selective evaluation method for DPP4 inhibitors based on
recombinant human DPP8 and DPP9 proteins
Jinglong Liu, Yi Huan, Caina Li, Minzhi Liu, Zhufang ShenState Key Laboratory of Bioactive Substances and Functions of Natural
Medicines, Diabetes Research Center, Institute of Materia Medica, Chinese
Academy of Medical Sciences and Peking Union Medical College, Beijing 100050,
China
A highly reproducible and selective method to evaluate the DPP8 and DPP9 selectivity for DPP4 inhibitor candidates based on recombinant
human DPP8 and DPP9 proteins expressed by Rosetta cells was established, which would provide valuable guidance in the development of safe
DPP4 inhibitors.
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Inhibition of tyrosinase activity and melanine pigmentation by 2-hydroxytyrosolRyuji Uchidaa,b, Seiko Ishikawaa, Hiroshi Tomodaa,b
aGraduate School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan
bSchool of Pharmacy, Kitasato University, Tokyo 108-8641, Japan
Hydroxytyrosol (2-HT), was found to inhibit mushroom tyrosinase activity (IC50, 32.5 mmol/L) in the
cell-free extract of B16 melanoma cells and α-melanocyte stimulating hormone (α-MSH)-stimulated
melanin formation in intact B16 melanoma cells.
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Comparative pharmacokinetics of zolpidem tartrate in ﬁve ethnic populations of China
a b c a cTao Guo , Guifu Mao , Longshan Zhao , Dongya Xia , Lu Yang
aDepartment of Pharmacy, Shenyang Northern Hospital, Shenyang 110840, China
bDepartment of Pharmacy, Women and Children Health Hospital of Liuzhou, Liuzhou 545001, China
cSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
The objective of this study was to evaluate the difference in the pharmacokinetics of zolpidem tatrate in subjects
from ﬁve Chinese ethnicities (Han, Mongolian, Uigur, Korean and Hui).
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Role of mucoadhesive polymers in enhancing delivery of nimodipine
microemulsion to brain via intranasal route
Rudree Pathaka, Ranjeet Prasad Dashb, Manju Misraa, Manish Nivsarkarb
aDepartment of Pharmaceutics, National Institute of Pharmaceutical Education
and Research-Ahmedabad, C/O – B. V. Patel Pharmaceutical Education and
Research Development (PERD) Centre, Ahmedabad 380054, Gujarat, India
bDepartment of Pharmacology and Toxicology, B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre,
Ahmedabad 380054, Gujarat, India
Intranasal delivery helps in bypassing the blood–brain barrier and targeting the therapeutics directly to the CNS. However, rapid mucociliary clearance
in nasal cavity is a major hurdle. To solve this problem, a novel mucoadhesive microemulsion system for nimodipine was developed which led
to improved brain drug delivery via intranasal route.Acta Pharmaceutica Sinica B, 4 (2014) 161
Enhancing production of ergosterol in Pichia pastoris GS115 by over-expression
of 3-hydroxy-3-methylglutaryl CoA reductase from Glycyrrhiza uralensis
Ying Liua, Xiaoqing Zhua, Wendong Lib, Hao Wena, Ya Gaoa, Yong Liua, Chunsheng Liua
aSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China
bDepartment of Antibiotics, Beijing Institute for Drug Control, Beijing 100102, China
Six recombinant Pichia pastoris strains containing different copy numbers of the GuHMGR gene
were obtained in this paper. HPLC analysis showed that the content of ergosterol in all recombinant
P. pastoris strains containing the GuHMGR gene was higher than in negative control. And with
the increase of copy number of the GuHMGR gene, the content of ergosterol was presented in
an increasing–decreasing–increasing pattern.
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Electronic circular dichroism behavior of chiral Phthiobuzone
Li Li, Lin Wang, Yikang Si
Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute
of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College,
Beijing 100050, China
The absolute conﬁgurations of chiral Phthiobuzones have been assigned by a combination of experimental
and theoretical electronic circular dichroism study.
